Researchers have developed a computational model that predicts the likelihood of developing long COVID based on blood protein analysis.
Proteins involved in immune responses, blood clotting, and inflammation may be key biomarkers for diagnosing and monitoring long COVID.
The study included 39 healthy adults and 113 people who had tested positive for COVID-19, 40 of whom had long COVID.